Ester Fonsatti

4.4k total citations
64 papers, 3.3k citations indexed

About

Ester Fonsatti is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ester Fonsatti has authored 64 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 31 papers in Immunology and 26 papers in Molecular Biology. Recurrent topics in Ester Fonsatti's work include Immunotherapy and Immune Responses (28 papers), Cell Adhesion Molecules Research (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Ester Fonsatti is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Cell Adhesion Molecules Research (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Ester Fonsatti collaborates with scholars based in Italy, United States and Australia. Ester Fonsatti's co-authors include Michele Maio, Maresa Altomonte, Luca Sigalotti, Sandra Coral, Luana Calabrò, Anna Maria Di Giacomo, Pier Giorgio Natali, Maria Rita Nicotra, Riccardo Danielli and Francesca Colizzi and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Ester Fonsatti

64 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Fonsatti Italy 28 1.7k 1.5k 974 704 440 64 3.3k
Farbod Shojaei United States 22 2.4k 1.4× 1.5k 1.0× 1.3k 1.4× 415 0.6× 891 2.0× 35 4.0k
Rizwan Naeem United States 8 1.7k 1.0× 2.0k 1.4× 774 0.8× 292 0.4× 928 2.1× 10 3.5k
Minal Barve United States 25 1.3k 0.8× 1.8k 1.2× 654 0.7× 659 0.9× 444 1.0× 179 2.9k
Nancy Dumont United States 23 2.5k 1.5× 1.9k 1.3× 545 0.6× 433 0.6× 735 1.7× 32 3.9k
Karen Pulford United Kingdom 27 1.2k 0.7× 1.5k 1.0× 825 0.8× 817 1.2× 247 0.6× 49 4.2k
Ann Cleverly United States 25 1.3k 0.8× 1.5k 1.0× 530 0.5× 333 0.5× 428 1.0× 54 2.6k
Emiliano Cocco United States 32 1.1k 0.6× 1.6k 1.1× 294 0.3× 833 1.2× 532 1.2× 83 3.2k
Oakley C. Olson United States 18 1.3k 0.8× 1.5k 1.0× 2.3k 2.3× 324 0.5× 702 1.6× 23 4.2k
Barbara Sennino United States 28 2.0k 1.2× 1.1k 0.8× 284 0.3× 698 1.0× 817 1.9× 47 3.8k
R Whitehouse United Kingdom 15 1.7k 1.0× 1.3k 0.9× 654 0.7× 348 0.5× 994 2.3× 21 2.8k

Countries citing papers authored by Ester Fonsatti

Since Specialization
Citations

This map shows the geographic impact of Ester Fonsatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Fonsatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Fonsatti more than expected).

Fields of papers citing papers by Ester Fonsatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Fonsatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Fonsatti. The network helps show where Ester Fonsatti may publish in the future.

Co-authorship network of co-authors of Ester Fonsatti

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Fonsatti. A scholar is included among the top collaborators of Ester Fonsatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Fonsatti. Ester Fonsatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weide, Benjamin, Anna Maria Di Giacomo, Ester Fonsatti, & Laurence Zitvogel. (2015). Immunologic Correlates in the Course of Treatment With Immunomodulating Antibodies. Seminars in Oncology. 42(3). 448–458. 16 indexed citations
2.
Maccalli, Cristina, Diana Giannarelli, Lorenzo Pilla, et al.. (2015). Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study. OncoImmunology. 5(2). e1071007–e1071007. 30 indexed citations
3.
Calabrò, Luana, Aldo Morra, Ester Fonsatti, et al.. (2015). A phase II study combining tremelimumab and durvalumab (MEDI4736) immunomodulating antibodies in mesothelioma patients: The NIBIT-MESO-1 study. Annals of Oncology. 26. viii5–viii5. 1 indexed citations
4.
Calabrò, Luana, Aldo Morra, Ester Fonsatti, et al.. (2015). Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study. The Lancet Respiratory Medicine. 3(4). 301–309. 151 indexed citations
5.
Calabrò, Luana, Aldo Morra, Ester Fonsatti, et al.. (2013). Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial. The Lancet Oncology. 14(11). 1104–1111. 258 indexed citations
6.
Colombino, Maria, Mariaelena Capone, Amelia Lissia, et al.. (2012). BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma. Journal of Clinical Oncology. 30(20). 2522–2529. 360 indexed citations
7.
Fonsatti, Ester, Michele Maio, Maresa Altomonte, & Peter Hersey. (2010). Biology and Clinical Applications of CD40 in Cancer Treatment. Seminars in Oncology. 37(5). 517–523. 34 indexed citations
8.
Kalbasi, Anusha, Ester Fonsatti, Pier Giorgio Natali, et al.. (2010). CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893. Journal of Immunotherapy. 33(8). 810–816. 19 indexed citations
9.
Fratta, Elisabetta, Luca Sigalotti, Francesca Colizzi, et al.. (2010). Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma. Journal of Cellular Physiology. 223(2). 352–358. 21 indexed citations
10.
Calabrò, Luana, Luca Sigalotti, Ester Fonsatti, et al.. (2010). Expression and regulation of B7‐H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: Immunotherapeutic implications. Journal of Cellular Physiology. 226(10). 2595–2600. 16 indexed citations
11.
Fonsatti, Ester, Hugues J. M. Nicolay, Maresa Altomonte, Alessia Covre, & Michele Maio. (2009). Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovascular Research. 86(1). 12–19. 138 indexed citations
12.
Sigalotti, Luca, Elisabetta Fratta, Sandra Coral, et al.. (2007). Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications. Journal of Cellular Physiology. 212(2). 330–344. 113 indexed citations
13.
Altomonte, Maresa, Alberto Visintin, Raffaele Tecce, et al.. (2004). Targeting of HLA‐DR molecules transduces agonistic functional signals in cutaneous melanoma. Journal of Cellular Physiology. 200(2). 272–276. 7 indexed citations
14.
Calabrò, Luana, Ester Fonsatti, Maresa Altomonte, et al.. (2004). Methylation‐regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications. Journal of Cellular Physiology. 202(2). 474–477. 22 indexed citations
15.
Fonsatti, Ester, Luca Sigalotti, Perihan Arslan, Maresa Altomonte, & Michele Maio. (2003). Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies. Current Cancer Drug Targets. 3(6). 427–432. 79 indexed citations
16.
Fonsatti, Ester, Luigi Del Vecchio, Maresa Altomonte, et al.. (2001). Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. Journal of Cellular Physiology. 188(1). 1–7. 151 indexed citations
17.
Coral, Sandra, Ester Fonsatti, Luca Sigalotti, et al.. (2000). Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement. Journal of Cellular Physiology. 185(3). 317–323. 22 indexed citations
18.
Altomonte, Maresa, Ester Fonsatti, Elda Lamaj, et al.. (1999). Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions. Breast Cancer Research and Treatment. 58(1). 19–23. 18 indexed citations
19.
Fonsatti, Ester, Maresa Altomonte, Sandra Coral, et al.. (1997). Tumour-derived interleukin 1α (IL-1α) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. British Journal of Cancer. 76(10). 1255–1261. 22 indexed citations
20.
Braşoveanu, Lorelei Irina, Maresa Altomonte, Annunziata Gloghini, et al.. (1995). Expression of protectin (CD59) in human melanoma and its functional role in cell‐ and complement‐mediated cytotoxicity. International Journal of Cancer. 61(4). 548–556. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farbod Shojaei Breakdown of academic impact, for papers by Rizwan Naeem Breakdown of academic impact, for papers by Minal Barve Breakdown of academic impact, for papers by Nancy Dumont Breakdown of academic impact, for papers by Karen Pulford Breakdown of academic impact, for papers by Ann Cleverly Breakdown of academic impact, for papers by Emiliano Cocco Breakdown of academic impact, for papers by Oakley C. Olson Breakdown of academic impact, for papers by Barbara Sennino Breakdown of academic impact, for papers by R Whitehouse
Rankless by CCL
2026